Patients with SSc were linked to an increased risk for hematological malignancies, specifically B-cell malignancies.
Jazz Pharmaceuticals plc today announced the appointment of Thomas Riga as Chief Business Officer, effective January 1, 2026.Mr. Riga joined Jazz in April 2025 through the acquisition of Chimerix Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback